Healing Gardens: Leveraging Serious Games to Deliver Accessible Pain-CBT and Pharmacologic Support for Patients With Advanced Cancer Managing Pain

NCT ID
NCT07825051
Registry status
Not yet recruiting
Study type
Interventional
Phase
Not applicable
Sponsor
Dana-Farber Cancer Institute
Conditions
Advanced Cancer, Cancer Pain, Chronic Pain

Overview

ClinicalTrials.gov lists this study as Not yet recruiting.

Enrollment: 46 participants (Estimated).

What is being studied

  • Behavioral: Healing Gardens content development/refinement activities
  • Behavioral: Healing Gardens serious game

Who may be eligible

Ages
18 Years to no maximum
Sex
All
Healthy volunteers accepted
No

ClinicalTrials.gov lists the following eligibility criteria.

Inclusion Criteria: * Age ≥ 18 years * Patient is diagnosed with a locally advanced or metastatic solid tumor malignancy, either undergoing active treatment or receiving treatment for an advanced cancer or are receiving supportive/palliative care at DFCI * Chronic pain related to cancer or treatment (\> pain score of 4 on a 0-10 scale on average over the past two weeks, Numeric Rating Scale) * Own/use a compatible device (e.g., smartphone, laptop) Exclusion Criteria: * Patients in survivorship: patients who have completed their treatment regimens, are not actively receiving curative or palliative treatment for an advanced cancer, or have a cancer that is in remission * Cognitive impairment that would interfere with study participation, as judged by the treating clinician (e.g. delirium, dementia) * Inability to speak English (the intervention has not yet been translated to other languages) * Enrolled in hospice * Currently hospitalized * Pain primarily related to a recent surgery (within the last 2 weeks) * Conditions that hinder device use (e.g., vision impairment) * We will exclude adults who are unable to consent, individuals who are not yet adults (infants, children, teenagers), pregnant women, and prisoners.

Study locations

2 study locations are listed.

Site recruitment status is not specified in the registry data for these locations.

Countries: United States

  • Massachusetts, United States: 2

Sample of listed locations

  • Dana-Farber Cancer Institute — Boston, Massachusetts, 02215, United States — Site recruitment status not specified in the registry data
  • Dana-Farber Cancer Institute at South Shore — Weymouth, Massachusetts, 02190, United States — Site recruitment status not specified in the registry data

Study details

Start date
February 13, 2027
Primary completion date
June 1, 2030
Completion date
June 1, 2030
First posted
September 17, 2026
Collaborators
National Cancer Institute (NCI)

Source and update information

Source
ClinicalTrials.gov
NCT ID
NCT07825051
Registry last updated
September 17, 2026
QualifiedStudies registry data refreshed
September 28, 2026
QualifiedStudies record fetched
September 28, 2026

View NCT07825051 on ClinicalTrials.gov

Trial information can change. Confirm current study details with the study team or the registry.

About joining clinical research

Find clinical trials you may match with

QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.

Find clinical trials you may match with | Chronic Pain studies | Clinical trial FAQ